Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of ASP1941 plus metformin vs placebo plus metformin in Asian adults with type 2 diabetes mellitus inadequately controlled on metformin
KCT0000365Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ipragliflozin in type 2 diabetes mellitus (T2DM), sponsored by Astellas Pharma. Started Nov 2011; status: completed.
02
Drugs
ipragliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on KCT0000365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000365.